Comparison between Ambey Laboratories IPO and Mason Infratech IPO.
Ambey Laboratories IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Mason Infratech IPO is a SME Bookbuilding proposed to list at NSE SME.
| Ambey Laboratories IPO | Mason Infratech IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Novus Capital Advisors Private Limited | Expert Global Consultants Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Nikunj Stock Brokers Ltd. | Globalworth Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Ambey Laboratories IPO is up to ₹42.43 Cr whereas the issue size of the Mason Infratech IPO is up to ₹28.93 Cr. The final issue price of Ambey Laboratories IPO is ₹68.00 per share and of Mason Infratech IPO is ₹64.00 per share.
| Ambey Laboratories IPO | Mason Infratech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹65.00 per share | ₹62.00 per share |
| Issue Price (Upper) | ₹68.00 per share | ₹64.00 per share |
| Issue Price (Final) | ₹68.00 per share | ₹64.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 2000 shares |
| Fresh Issue Size | 59,28,000 shares | 45,20,000 shares |
| Fresh Issue Size (Amount) | up to ₹40.31 Cr | up to ₹28.93 Cr |
| OFS Issue Size | 3,12,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹2.12 Cr | up to ₹0.00 Cr |
| Issue Size Total | 62,40,000 shares | 45,20,000 shares |
| Issue Size Total (Amount) | up to ₹42.43 Cr | up to ₹28.93 Cr |
Ambey Laboratories IPO opens on Jul 04, 2024, while Mason Infratech IPO opens on Jun 24, 2024. The closing date of Ambey Laboratories IPO and Mason Infratech IPO is Jul 08, 2024, and Jun 26, 2024, respectively.
| Ambey Laboratories IPO | Mason Infratech IPO | |
|---|---|---|
| Anchor Bid Date | Jul 03, 2024 | Jun 21, 2024 |
| Issue Open | Jul 04, 2024 | Jun 24, 2024 |
| Issue Close | Jul 08, 2024 | Jun 26, 2024 |
| Basis Of Allotment (Tentative) | Jul 09, 2024 | Jun 27, 2024 |
| Initiation of Refunds (Tentative) | Jul 10, 2024 | Jun 28, 2024 |
| Credit of Share (Tentative) | Jul 10, 2024 | Jun 28, 2024 |
| Listing date (Tentative) | Jul 11, 2024 | Jul 01, 2024 |
| Anchor Lockin End date 1 | Aug 08, 2024 | Jul 27, 2024 |
| Anchor Lockin End date 2 | Oct 07, 2024 | Sep 25, 2024 |
Ambey Laboratories IPO P/E ratio is 27.81, as compared to Mason Infratech IPO P/E ratio of 24.33.
| Ambey Laboratories IPO | Mason Infratech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 94.97 | 98.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.9 | 71.60 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 27.81 | 24.33 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹171.64 Cr. | ₹112.46 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 20.80% | 43.47% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 13.14% | 30.98% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.58 | 0.94 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.44 | ₹2.63 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20.80% | 43.47% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Ambey Laboratories IPO Retail Individual Investors (RII) are offered 21,84,000 shares while in Mason Infratech IPO retail investors are offered 21,84,000 shares. Qualified Institutional Buyers (QIB) are offered 12,48,000 shares in Ambey Laboratories IPO and 9,04,000 shares in Mason Infratech IPO.
| Ambey Laboratories IPO | Mason Infratech IPO | |
|---|---|---|
| Anchor Investor Reservation | 18,72,000 shares | 13,52,000 shares |
| Market Maker Reservation | 3,30,000 shares | 2,40,000 shares |
| QIB | 12,48,000 shares | 9,04,000 shares |
| NII | 9,36,000 shares | 6,80,000 shares |
| RII | 21,84,000 shares | 15,84,000 shares |
| Employee | ||
| Others | ||
| Total | 62,40,000 shares | 45,20,000 shares |
Ambey Laboratories IPO subscribed 173.18x in total, whereas Mason Infratech IPO subscribed 32.89x.
| Ambey Laboratories IPO | Mason Infratech IPO | |
|---|---|---|
| QIB (times) | 61.90x | 13.40x |
| NII (times) | 324.22x | 50.20x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 195.06x | 36.59x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 173.18x | 32.89x |
